MARC Record from harvard_bibliographic_metadata

LEADER: 05322cam a2200469 a 4500
001 012247528-3
005 20100621191247.0
008 091203s2010 njua b 001 0 eng
015 $aGBA9C3364$2bnb
016 7 $a015443190$2Uk
020 $a9781607616085 (hbk.)
020 $a1607616084 (hbk.)
035 0 $aocn462919590
040 $aUKM$cUKM$dBTCTA$dYDXCP
050 00 $aRC262$b.C291165 2010
060 00 $aW1$bME9616J v.624 2010
060 10 $aQZ 241
082 04 $a616.994$222
245 00 $aCancer nanotechnology :$bmethods and protocols /$cedited by Stephen R. Grobmyer and Brij M. Moudgil.
260 $aTotowa, N.J. :$bHumana ;$aLondon :$bSpringer [distributor],$c2010.
300 $axiii, 396 p. :$bill. ;$c27 cm.
490 1 $aMethods in molecular biology ;$v624
490 1 $aSpringer protocols
504 $aIncludes bibliographical references and index.
505 00 $g1.$tWhat Is cancer nanotechnology? /$rStephen R. Grobmyer, Nobutaka Iwakuma, Parvesh Sharma, and Brij M. Moudgil --$g2.$tMolecular-targeted therapy for cancer and nanotechnology /$rSteven N. Hochwald --$g3.$tEnhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting /$rKhaled Greish --$g4.$tNanoparticle characterization for cancer nanotechnology and other biological applications /$rScott C. Brown, Maria Palazuelos, Parvesh Sharma, Kevin W. Powers, Stephen M. Roberts, Stephen R. Grobmyer, and Brij M. Moudgil --$g5.$tMultimodal nanoparticulate bioimaging contrast agents /$rParvesh Sharma, Amit Singh, Scott C. Brown, Niclas Bengtsson, Glenn A. Walter, Stephen R. Grobmyer, Nobutaka Iwakuma, Swadeshmukul Santra, Edward W. Scott, and Brij M. Moudgil --$g6.$tGold nanocages for cancer imaging and therapy /$rLeslie Au, Jingyi Chen, Lihong V. Wang, and Younan Xia --$g7.$tNanoshells for photothermal cancer therapy /$rJennifer G. Morton, Emily S. Day, Naomi J. Halas, and Jennifer L. West --$g8.$tGold nanorods: multifunctional agents for cancer imaging and therapy /$rAlexander Wei, Alexei P. Leonov, and Qingshan Wei --$g9.$tPolymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example /$rRupa R. Sawant and Vladimir P. Torchilin --$g10.$tFluorescent silica nanoparticles for cancer imaging /$rSwadeshmukul Santra --$g11.$tPolymeric nanoparticles for drug delivery /$rJuliana M. Chan, Pedro M. Valencia, Liangfang Zhang, Robert Langer, and Omid C. Farokhzad --$g12.$tSynthesis, characterization, and functionalization of gold nanoparticles for cancer imaging /$rGary A. Craig, Peter J. Allen, and Michael D. Mason --$g13.$tIdentification of pancreatic cancer-specific cell-surface markers for development of targeting ligands /$rDavid L. Morse, Galen Hostetter, Yoganand Balagurunathan, Robert J. Gillies, and Haiyong Han.
505 00 $g14.$tPreparation and characterization of doxorubicin liposomes /$rGuoqin Niu, Brian Cogburn, and Jeffrey Hughes --$g15.$tPEGylated nanocarriers for systemic delivery /$rN.K. Jain and Manoj Nahar --$g16.$tNanoparticle-aptamer conjugates for cancer cell targeting and detection /$rM. Carmen Estévez, Yu-Fen Huang, Huaizhi Kang, Meghan B. O'Donoghue, Suwussa Bamrungsap, Jilin Yan, Xiaolan Chen, and Weihong Tan --$g17.$tTargeting of nanoparticles: folate receptor /$rSumith A. Kularatne and Philip S. Low --$g18.$tMagnetic aerosol targeting of nanoparticles to cancer: nanomagnetosols /$rCarsten Rudolph, Bernhard Gleich, and Andreas W. Flemmer --$g19.$tLHRH-targeted nanoparticles for cancer therapeutics /$rTamara Minko, Mahesh L. Patil, Min Zhang, Jayant J. Khandare, Maha Saad, Pooja Chandna, and Oleh Taratula --$g20.$tAntibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes /$rMiriam Rothdiener, Julia Beuttler, Sylvia K.E. Messerschmidt, and Roland E. Kontermann --$g21.$tPhotoacoustic tomography for imaging nanoparticles /$rZhen Yuan and Huabei Jiang --$g22.$tCurrent applications of nanotechnology for magnetic resonance imaging of apoptosis /$rGustav J. Strijkers, Geralda A.F. van Tilborg, Tessa Geelen, Chris P.M. Reutelingsperger, and Klaas Nicolay --$g23.$tApplications of gold nanorods for cancer imaging and photothermal therapy /$rXiaohua Huang, Ivan H. El-Sayed, and Mostafa A. El-Sayed --$g24.$tUse of nanoparticles for targeted, noninvasive thermal destruction of malignant cells /$rPaul Cherukuri and Steven A. Curley --$g25.$tColloidal gold: a novel nanoparticle for targeted cancer therapeutics /$rAnathea C. Powell, Giulio F. Paciotti, and Steven K. Libutti --$g26.$tLiposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use /$rAlexander Gaitanis and Stephen Staal.
650 12 $aNanotechnology.
650 12 $aNeoplasms$xtherapy.
650 12 $aNeoplasms$xdiagnosis.
650 0 $aCancer$xDiagnosis.
650 0 $aCancer$xTreatment.
650 0 $aNanomedicine.
650 0 $aNanotechnology.
650 22 $aNanostructures$xdiagnostic use.
650 22 $aNanotechnology$xmethods.
700 1 $aGrobmyer, Stephen R.
700 1 $aMoudgil, Brij M.
776 08 $iOnline version:$tCancer nanotechnology.$dNew York, N.Y. : Humana Press, ©2010$z9781607616092$w(OCoLC)556150096
830 0 $aSpringer protocols.
830 0 $aMethods in molecular biology (Clifton, N.J.) ;$v624.
988 $a20100318
906 $0OCLC